Related Experiment Video
Updated: Jul 19, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Aspirin for the primary prevention of cardiovascular events
1Medical University of South Carolina, Charleston, South Carolina, USA.
Insights
Low-dose aspirin effectively prevents myocardial infarction in men and ischemic stroke in women. While risks like gastrointestinal bleeding exist, benefits often outweigh risks for individuals with elevated cardiovascular disease risk.
Area of Science:
- Cardiology
- Gastroenterology
- Neurology
Background:
- Low-dose aspirin is recognized for primary prevention of cardiovascular events.
- Evidence suggests efficacy in preventing myocardial infarction (MI) in men and ischemic stroke in women.
- Potential risks include gastrointestinal (GI) bleeding and hemorrhagic stroke.
Purpose of the Study:
- To evaluate the net benefit of low-dose aspirin therapy in primary cardiovascular event prevention.
- To assess the balance between aspirin's benefits and bleeding risks in specific populations.
Main Methods:
- Review of existing evidence on low-dose aspirin for primary prevention.
- Analysis of risks including major GI hemorrhage and hemorrhagic stroke.
- Consideration of risk factors like history of ulcer disease and Helicobacter pylori infection.
Main Results:
- Significant evidence supports aspirin's role in preventing first MI in men and ischemic stroke in women.
- An increased risk of major GI hemorrhage is noted.
- A non-significant increase in hemorrhagic stroke risk was observed.
Conclusions:
- The benefits of low-dose aspirin (75-162 mg/day) generally outweigh the risks of serious bleeding.
- Therapy is recommended for adults with coronary heart disease risk >1% per year or >1% in 10 years.
- For patients with ulcer history, H. pylori eradication and PPI use are advised with aspirin.
Abstract:
There is significant evidence that low-dose aspirin is effective in preventing the first myocardial infarction in men and ischemic stroke in women. There is also an increased risk for major gastrointestinal tract hemorrhage and a suggestive, but nonsignificant, increase in the risk for hemorrhagic stroke. If there is a history of ulcer disease or upper-gastrointestinal tract bleeding, Helicobacter pylori should be eradicated (if present) and a proton pump inhibitor used with aspirin therapy. In conclusion, the benefits of low-dose aspirin (75-162 mg/day) in the prevention of myocardial infarction in men and thrombotic stroke in women generally outweigh the risks of serious bleeding in adults with a coronary heart disease risk >1% per year or >1% in 10 years.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Cardiovascular Drugs: Classification based on Therapeutic Indications
